Skip to main navigation Skip to search Skip to main content

Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection

  • Rohit P. Ojha
  • , Brooke R. MacDonald
  • , Tzu Chun Chu
  • , Esther O. Fasanmi
  • , Jonathan D. Moore
  • , Rachel A. Stewart

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)585-592
Number of pages8
JournalAntiviral Therapy
Volume23
Issue number7
DOIs
StatePublished - 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection'. Together they form a unique fingerprint.

Cite this